Spécificités du traitement médicamenteux antihypertenseur chez la femme

Jacques Amar; Theodora Angoulvant; Jean Marc Boivin; Laurence Amar; Pierre Lantelme; Jacques Blacher; Geneviève Plu-Bureau; Claire Mounier Vehier

doi:10.1016/j.lpm.2019.07.028

Spécificités du traitement médicamenteux antihypertenseur chez la femme

Presse Med. 2019 Nov;48(11 Pt 1):1261-1264. doi: 10.1016/j.lpm.2019.07.028. Epub 2019 Nov 14.

[Article in French]

Authors

Jacques Amar¹, Theodora Angoulvant², Jean Marc Boivin², Laurence Amar², Pierre Lantelme², Jacques Blacher², Geneviève Plu-Bureau², Claire Mounier Vehier²

Affiliations

¹ CHU de Toulouse, fédération de cardiologie, service d'HTA, avenue Jean-Pouhles, Toulouse, France. Electronic address: amar.j@chu-toulouse.fr.
² CHU de Toulouse, fédération de cardiologie, service d'HTA, avenue Jean-Pouhles, Toulouse, France.

PMID: 31735525
DOI: 10.1016/j.lpm.2019.07.028

Abstract

The impact of antihypertensive drugs on blood pressure does not differ according to the sex. There are women-specific conditions or medical conditions encountered more frequently among womens that guide the selection of therapy such as a desire to become pregnant, a pregnancy, a polycystic ovarian syndrome, breast cancer, osteoporosis or migraine.

Publication types

Review

MeSH terms

Age Factors
Antihypertensive Agents / adverse effects
Antihypertensive Agents / therapeutic use*
Blood Pressure / drug effects
Breast Neoplasms / chemically induced
Female
Humans
Hypertension / drug therapy*
Migraine Disorders
Osteoporosis / complications
Osteoporosis / drug therapy
Polycystic Ovary Syndrome / drug therapy
Pregnancy
Sex Factors
Spironolactone / adverse effects

Substances

Antihypertensive Agents
Spironolactone